NUTX vs ASTH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 05, 2026

NUTX

62.3
AI Score
VS
NUTX Wins

ASTH

56.7
AI Score

Investment Advisor Scores

NUTX

62score
Recommendation
BUY

ASTH

57score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NUTX ASTH Winner
Forward P/E 0 23.0415 Tie
PEG Ratio 0 0 Tie
Revenue Growth 2.2% 55.6% ASTH
Earnings Growth 95.9% 110.1% ASTH
Tradestie Score 62.3/100 56.7/100 NUTX
Profit Margin 10.9% 0.9% NUTX
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD NUTX

Frequently Asked Questions

Based on our detailed analysis, NUTX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.